Doug Leone Family Fund

The Doug Leone Family Fund is a private investment vehicle and family office for Douglas Leone, a billionaire venture capitalist and former Global Managing Partner of Sequoia Capital. The fund manages the personal wealth of the Leone family, focusing on high-impact investments across the technology and life sciences sectors. It is recognized for its strategic participation in the biotechnology industry, notably as an investor in Soley Therapeutics, a company utilizing AI-enabled cell stress sensing for drug discovery. The fund leverages Doug Leone's extensive background in scaling global enterprises to support innovative startups in oncology, neurodegeneration, and metabolic diseases. It operates as a private entity and frequently co-invests with other leading venture capital and life science investment firms. The fund's involvement in the sector was highlighted by its participation in Soley Therapeutics' $200 million Series C financing in early 2026.